Throughout the pandemic, digital health companies have seen significant growth, with one study finding that U.S.-based digital health startups surpassed $29 billion in 2021, almost twice the funding seen in 2020. When done correctly, the use of these digital innovations can help people reduce the burden of dealing with mental health challenges by providing accessible, affordable, and timely care to users. As digital mental health interventions (DMHI) continue to battle it out for a leading spot
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Vivalink Integrates with Garmin, Other Wearables to Address RPM Interoperability
What You Should Know:
- Vivalink is addressing these RPM interoperability challenges by announcing today that leading wearables and medical-grade devices are integrating with the company’s Biometrics Data Platform.
- Now, leading pulse oximeters, blood glucose monitors and sleep monitors by companies like Garmin and Roche are available alongside the Platform to accelerate development and deployment of novel healthcare applications and research.
Why It Matters
Integration and
Read More
Non-Invasive, Precision-Based Approaches for Diagnosis and Treatment of Inflammatory Skin Conditions
Inflammatory skin conditions such as atopic dermatitis, psoriasis, vitiligo, hidradenitis suppurativa and others impact a significant portion of the U.S. population. In fact, nearly half of all visits to primary care physicians include some level of dermatological indication. Many of these dermatologic conditions are accompanied by pain and severe discomfort for affected patients, and the resulting morbidity of the condition may have a negative impact on mental health, self-esteem and overall
Read More
The $2.8M Medicine: How Data Can Help Insurers Pay for Life-Changing Therapies Without Breaking The Bank
Advanced medical research has brought us to the point where many serious conditions can potentially be treated and even cured - with people who have essentially faced a lifetime of being incapacitated finally able to conduct normal lives. Many of these treatments are drug-based gene therapies–- but they come with an extremely high price tag. The latest example–and most expensive medication to date– is bluebird bio’s recently-approved $2.8 million gene therapy to treat a rare blood
Read More
HLTH22 Day 1 News Summary: Google, Maven, Highmark, LG, Others
Venture Capital, Private Equity Funding
Maven Clinic Secures $90M to Advance End-to-End Family Care Platform
Maven Clinic, the largest virtual clinic in women’s and family health raises $90 million Series E funding bringing its total funding to $300M. Maven plans to use the latest round of funding to advance its end-to-end family care platform to enable deeper personalization to meet the diverse needs of women and families everywhere.
Curavit Raises $5M for Digital Therapeutics
Read More
HLTH22: Curavit Raises $5M for Digital Therapeutics Clinical Research
What You Should Know:
- Curavit Clinical Research, a virtual contract research organization (VCRO) that specializes in decentralized clinical trials (DCTs) announced it raised $5M in Series A funding to accelerate its growing portfolio of research in the global digital therapeutics (DTx) market. The round was led by Osage Venture Partners with additional investment from Royal Street Ventures and Narrow Gauge Ventures.
- The new funding will be used to expand
Read More
ConcertAI CEO Talks COVID-19 & The De-Risking of Technology to Keep Trials Moving
Nothing like it had ever happened before – a global slowdown in new study starts and a massive decrease in trial accruals for open studies. The turn of events was a shock for sponsors and providers. Sudden disruptions on that scale rarely hit multiple players in an ecosystem at the same time. But that’s exactly what happened at the intersection of clinical care and clinical development during the pandemic. Researchers and clinicians were forced to change how they operated trials, and
Read More
PointClickCare & Pfizer Launches Real World Data Collaboration
What You Should Know:
- PointClickCare announced a collaboration with Pfizer Inc. to provide real-world insights for vulnerable populations at high risk of age-related disorders (including Cachexia) – further enhancing PCC’s mission to protect and support the senior population.
- With coverage approaching 70% of the long-term and post-acute care (LTPAC) market, PointClickCare is uniquely positioned to provide life sciences companies, like Pfizer, with outcomes-based evidence through
Read More
Forrester Unveils 5 Healthcare Predictions for 2023
What You Should Know:
- A new dawn is on the horizon in healthcare. Equipped with new digital capabilities and pressured by new consumer expectations for personalized, convenient experiences, healthcare organizations face a predicament — act now and stay afloat, fail to act and get consumed by the competition, or risk financial ruin.
- Market research leader Forrester’s latest report explores 5 key predictors for healthcare in 2023.
Healthcare in the Era Post-Covid
COVID-19
Read More
3 Reasons to Implement an IDMP Solution Early
The European Union (EU) has announced guidance on the Identification of Medicinal Product (IDMP) — and pharmaceutical companies around the world should take notice. While the EU will be the first to design and implement IDMP, other countries, including the United States, will need to begin following suit. It’s imperative that companies begin evaluating what changes need to be implemented, and the sooner pharmaceutical companies act, the better.
Designed to connect data elements and
Read More
